SCHEMBL4334570

SCHEMBL4334570

COc1c(C(=O)O)ccc2c1c(-c1cc3ccccc3o1)nn2C(SC)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.39
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
ALDH1A1 P00352 7/20 0.39
MAPT P10636 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.34
GALR3 O60755 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348179 0.83 SRC (0.37) KDM4EALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL4341551 0.83 ALDH1A1 (0.37) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL4331228 0.81 KDM4E (0.36) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL4348191 0.78 KDM4E (0.35) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL4331301 0.72 KDM4E (0.41) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL2872405 0.71 MAPT (0.41) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL2866727 0.69 JAK2 (0.42) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL4341027 0.69 KDM4E (0.40) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL4331815 0.68 JAK2 (0.37) KDM4EALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL4332922 0.66 JAK2 (0.39) JAK2JAK3PLAUKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885MEN1 3782/4885KMT2A 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.